Martiniano Bello

InstitutionLaboratorio de Modelado Molecular y diseño de fármacos de la Escuela Superior de Medicina
AddressMexico
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 2 publications in June 2021
    All Publications
    Bar chart showing 54 publications over 13 distinct years, with a maximum of 11 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Bello M, Hasan MK, Hussain N. Energetic and structural basis for the differences in infectivity between the wild-type and mutant spike proteins of SARS-CoV-2 in the Mexican population. J Mol Graph Model. 2021 09; 107:107970. PMID: 34242876.
      Citations:    Fields:    Translation:HumansCells
    2. Bello M, Hasan MK. Elucidation of the inhibitory activity of plant-derived SARS-CoV inhibitors and their potential as SARS-CoV-2 inhibitors. J Biomol Struct Dyn. 2021 Jun 14; 1-13. PMID: 34121618.
      Citations:    Fields:    
    3. Bello M. Elucidation of the inhibitory activity of ivermectin with host nuclear importin a and several SARS-CoV-2 targets. J Biomol Struct Dyn. 2021 Apr 10; 1-9. PMID: 33843474.
      Citations: 2     Fields:    
    4. Hasan MK, Kamruzzaman M, Bin Manjur OH, Mahmud A, Hussain N, Alam Mondal MS, Hosen MI, Bello M, Rahman A. Structural analogues of existing anti-viral drugs inhibit SARS-CoV-2 RNA dependent RNA polymerase: A computational hierarchical investigation. Heliyon. 2021 Mar; 7(3):e06435. PMID: 33693066.
      Citations: 2     
    5. Sixto-López Y, Correa-Basurto J, Bello M, Landeros-Rivera B, Garzón-Tiznado JA, Montaño S. Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population. Sci Rep. 2021 02 25; 11(1):4659. PMID: 33633229.
      Citations: 4     Fields:    Translation:HumansCells
    6. Bello M, Martínez-Muñoz A, Balbuena-Rebolledo I. Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA. J Mol Model. 2020 Nov 12; 26(12):340. PMID: 33184722.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    7. Bello M. Prediction of potential inhibitors of the dimeric SARS-CoV2 main proteinase through the MM/GBSA approach. J Mol Graph Model. 2020 12; 101:107762. PMID: 33022569.
      Citations: 8     Fields:    Translation:Cells